| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35a481a4276d26c313a0630e9e5ed8e0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06034 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0812
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-07 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-097
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate |
2012-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_334fe8b3d21fe1074de115c1e678cf5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4089461d6644bf918d06303fb57b9fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a502d171b3bea5d8058f5320b0b35eb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbe7d0e318a284ee516d6cff6063e30f |
| publicationDate |
2014-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-102617705-B |
| titleOfInvention |
Macrocyclic Compounds Inhibiting Hepatitis C Virus Replication |
| abstract |
The compounds involved in the present invention are inhibitors of one or more hepatitis C virus replication. In addition, the present invention describes the use of pharmaceutical components and preparations containing the compound, and the inhibitor of the replication of hepatitis C virus, which can be used alone or in combination with other compounds to treat symptoms caused by hepatitis C virus infection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104169293-A |
| priorityDate |
2012-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |